Table 5 Statistical comparison between different Barcelona stages in HCC patients regarding p16 methylation status using Fisher’s exact test
From: Aberrant p16 methylation as an early diagnostic marker in blood of hepatocellular carcinoma patients
P16 methylation status | Stage | Fisher | p value | ||
|---|---|---|---|---|---|
A, n = 14 | B, n = 7 | C, n = 9 | |||
Methylated | 12/14 (85.7%) | 6/7 (85.7%) | 8/9 (88.9%) | 0.055 | > 0.05 |
Unmethylated | 2/14 (14.3%) | 1/7 (14.3%) | 1/9 (11.1%) | ||